This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* Rescue PCI: Background, Current Status, and Future in the Management of AMI
* Case Presentation
* Physical Exam and ECG
* Case Presentation
* Questions
* Importance of Open Arteries
* Quantitative Review: 23 Trials
* C-PORT Primary Endpoint Through 6 Months (ITT)
* Transfer: PPCI vs Onsite Lytic
* Prague-II: 30-day Mortality Transfer for PCI vs Onsite Thrombolysis in AMI (N = 850)
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
The guest, Anthony Gershlick, MD, has indicated that he receives research/grant support
from, is a consultant for and receives honorarium from Cordis, Medtronic Corp, Guidant
Corp and Boston Scientific.
The fellow, George Adams, MD, has indicated that he has no conflicts to disclose.
|
|